2019-01-31 Comments Off on Discovery points to innovative new way to treat Duchenne muscular dystrophy Discovery points to innovative new way to treat Duchenne muscular dystrophy Researchers at The Ottawa Hospital and the University of Ottawa
2018-09-06 Comments Off on Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy August 30, 2018 – Pfizer Inc. (NYSE: PFE) announced today